Onderneming Amarillo Biosciences, Inc. Other OTC
Aandelen
AMAR
US02301P2056
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Point-of-care Testing
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -96,53% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -96,53% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15-04-21 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 01-08-21 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Chih-Heng Lu
PRN | Corporate Officer/Principal | 44 | 11-08-21 |
Junyong Lee
LAW | General Counsel | 54 | 01-08-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 15-04-21 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 15-06-22 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 15-04-21 |
Chung Jung Tsai
BRD | Director/Board Member | 52 | 15-04-21 |
Ting Chuan Lee
BRD | Director/Board Member | 40 | 15-04-21 |
Wen Han Chang
BRD | Director/Board Member | 60 | 15-04-21 |
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 6 144 506 | 2 857 736 ( 46,51 %) | 0 | 46,51 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,42% | 114 mld. | |
+11,84% | 104 mld. | |
-14,15% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,16% | 17,89 mld. | |
+7,99% | 14,28 mld. | |
+36,24% | 12,55 mld. |